Danish pharmaceutical giant Novo Nordisk announced 9,000 redundancies on Wednesday in response to lowered growth forecasts ...

Working-age Americans who get health insurance through their job will see largest health insurance rate hikes since 2010.

One of them is already a leader in the market for weight management drugs, and the other could join this field.

Novo Nordisk, the Danish drugmaker behind blockbuster weight-loss drug Wegovy, is embarking on one of its deepest ...

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

As evidence grows supporting the potential health benefits of obesity drugs like Novo Nordisk’s Wegovy and Eli Lilly & Co.’s Zepbound, so too — frustratingly — do the barriers to accessing them.

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

Novo Nordisk will lay off 9,000 employees worldwide as part of a restructuring plan, redirecting savings to diabetes and obesity drug growth.

The draft assessment finds that the popular weight loss drugs are costly but worth the price tag, while also urging for ...

The maker of the popular weight-loss drug Wegovy announced on Wednesday that it will be cutting 9,000 jobs in the company.

The Danish pharmaceutical company will reduce its 78,400-person workforce by approximately 9,000 positions to streamline ...